USPSTF GUIDELINES - ABFM BOARD
EXAM QUESTIONS AND ANSWERS
GRADED A+ 2025/2026
Abdominal Aortic Aneurysm: Screening: men aged 65 to 75 years who have ever smoked -
ANS The USPSTF recommends 1-time screening for abdominal aortic aneurysm (AAA) with
ultrasonography in men aged 65 to 75 years who have ever smoked.
Anxiety Disorders in Adults: Screening: adults 64 years or younger, including pregnant and
postpartum persons - ANS The USPSTF recommends screening for anxiety disorders in adults,
including pregnant and postpartum persons.
Anxiety in Children and Adolescents: Screening: children and adolescents aged 8 to 18 years -
ANS The USPSTF recommends screening for anxiety in children and adolescents aged 8 to 18
years.
Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive
Medication: pregnant persons at high risk for preeclampsia - ANS The USPSTF recommends
the use of low-dose aspirin (81 mg/day) as preventive medication after 12 weeks of gestation in
persons who are at high risk for preeclampsia. See the Practice Considerations section for
information on high risk and aspirin dose.
Asymptomatic Bacteriuria in Adults: Screening: pregnant persons - ANS The USPSTF
recommends screening for asymptomatic bacteriuria using urine culture in pregnant persons.
1 @COPYRIGHT 2025/2026 ALLRIGHTS RESERVED.
, BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing: women with a
personal or family history of breast, ovarian, tubal, or peritoneal cancer or an ancestry
associated with brca1/2 gene mutation - ANS The USPSTF recommends that primary care
clinicians assess women with a personal or family history of breast, ovarian, tubal, or peritoneal
cancer or who have an ancestry associated with breast cancer susceptibility 1 and 2 (BRCA1/2)
gene mutations with an appropriate brief familial risk assessment tool. Women with a positive
result on the risk assessment tool should receive genetic counseling and, if indicated after
counseling, genetic testing.
Breast Cancer: Medication Use to Reduce Risk: women at increased risk for breast cancer aged
35 years or older - ANS The USPSTF recommends that clinicians offer to prescribe risk-
reducing medications, such as tamoxifen, raloxifene, or aromatase inhibitors, to women who are
at increased risk for breast cancer and at low risk for adverse medication effects.
Breast Cancer: Screening: women aged 50 to 74 years - ANS The USPSTF recommends
biennial screening mammography for women aged 50 to 74 years. †
Breastfeeding: Primary Care Interventions: pregnant women, new mothers, and their children -
ANS The USPSTF recommends providing interventions during pregnancy and after birth to
support breastfeeding.
Cervical Cancer: Screening: women aged 21 to 65 years - ANS The USPSTF recommends
screening for cervical cancer every 3 years with cervical cytology alone in women aged 21 to 29
years. For women aged 30 to 65 years, the USPSTF recommends screening every 3 years with
cervical cytology alone, every 5 years with high-risk human papillomavirus (hrHPV) testing
alone, or every 5 years with hrHPV testing in combination with cytology (cotesting). See the
Clinical Considerations section for the relative benefits and harms of alternative screening
strategies for women 21 years or older.
Chlamydia and Gonorrhea: Screening: sexually active women, including pregnant persons -
ANS The USPSTF recommends screening for gonorrhea in all sexually active women 24 years
or younger and in women 25 years or older who are at increased risk for infection.
2 @COPYRIGHT 2025/2026 ALLRIGHTS RESERVED.
EXAM QUESTIONS AND ANSWERS
GRADED A+ 2025/2026
Abdominal Aortic Aneurysm: Screening: men aged 65 to 75 years who have ever smoked -
ANS The USPSTF recommends 1-time screening for abdominal aortic aneurysm (AAA) with
ultrasonography in men aged 65 to 75 years who have ever smoked.
Anxiety Disorders in Adults: Screening: adults 64 years or younger, including pregnant and
postpartum persons - ANS The USPSTF recommends screening for anxiety disorders in adults,
including pregnant and postpartum persons.
Anxiety in Children and Adolescents: Screening: children and adolescents aged 8 to 18 years -
ANS The USPSTF recommends screening for anxiety in children and adolescents aged 8 to 18
years.
Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive
Medication: pregnant persons at high risk for preeclampsia - ANS The USPSTF recommends
the use of low-dose aspirin (81 mg/day) as preventive medication after 12 weeks of gestation in
persons who are at high risk for preeclampsia. See the Practice Considerations section for
information on high risk and aspirin dose.
Asymptomatic Bacteriuria in Adults: Screening: pregnant persons - ANS The USPSTF
recommends screening for asymptomatic bacteriuria using urine culture in pregnant persons.
1 @COPYRIGHT 2025/2026 ALLRIGHTS RESERVED.
, BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing: women with a
personal or family history of breast, ovarian, tubal, or peritoneal cancer or an ancestry
associated with brca1/2 gene mutation - ANS The USPSTF recommends that primary care
clinicians assess women with a personal or family history of breast, ovarian, tubal, or peritoneal
cancer or who have an ancestry associated with breast cancer susceptibility 1 and 2 (BRCA1/2)
gene mutations with an appropriate brief familial risk assessment tool. Women with a positive
result on the risk assessment tool should receive genetic counseling and, if indicated after
counseling, genetic testing.
Breast Cancer: Medication Use to Reduce Risk: women at increased risk for breast cancer aged
35 years or older - ANS The USPSTF recommends that clinicians offer to prescribe risk-
reducing medications, such as tamoxifen, raloxifene, or aromatase inhibitors, to women who are
at increased risk for breast cancer and at low risk for adverse medication effects.
Breast Cancer: Screening: women aged 50 to 74 years - ANS The USPSTF recommends
biennial screening mammography for women aged 50 to 74 years. †
Breastfeeding: Primary Care Interventions: pregnant women, new mothers, and their children -
ANS The USPSTF recommends providing interventions during pregnancy and after birth to
support breastfeeding.
Cervical Cancer: Screening: women aged 21 to 65 years - ANS The USPSTF recommends
screening for cervical cancer every 3 years with cervical cytology alone in women aged 21 to 29
years. For women aged 30 to 65 years, the USPSTF recommends screening every 3 years with
cervical cytology alone, every 5 years with high-risk human papillomavirus (hrHPV) testing
alone, or every 5 years with hrHPV testing in combination with cytology (cotesting). See the
Clinical Considerations section for the relative benefits and harms of alternative screening
strategies for women 21 years or older.
Chlamydia and Gonorrhea: Screening: sexually active women, including pregnant persons -
ANS The USPSTF recommends screening for gonorrhea in all sexually active women 24 years
or younger and in women 25 years or older who are at increased risk for infection.
2 @COPYRIGHT 2025/2026 ALLRIGHTS RESERVED.
